AstraZeneca plc (AZN) Stock Investment Calculator & Historical Return Analysis
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, manufacturing and commercialization of prescription medicines in Oncology, Rare Disease and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Investors often view AstraZeneca plc as a key player in the market, analyzing its long-term potential through various revenue models, brand recognition, and consistent presence in its industry.
This AstraZeneca plc stock investment calculator allows you to explore how a hypothetical investment in AZN might have performed over time. By adjusting the investment amount and time period, you can visualize potential growth, compare outcomes across different market cycles, and better understand the impact of long-term investing.
What if you invested $1000 in AZN on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Understanding AstraZeneca plc's Historical Performance
AstraZeneca plc's stock performance has historically reflected both broader market trends and company-specific milestones. Like many growth-oriented stocks, AZN has experienced periods of growth driven by innovation and market demand.
When analyzing AstraZeneca plc's historical returns, it's important to consider:
- Market cycles: Strong bull markets often amplify returns, while recessions can temporarily suppress performance.
- Business model evolution: Changes in revenue strategies and product lines can significantly impact stability.
- Long-term trends: Over extended periods, compounding can play a larger role than short-term price fluctuations. Try our calculator to explore returns over 5 years or larger investments over 10 years.
This calculator helps you see how these factors might have affected an investment depending on when you entered the market.
Historical Annual Returns
Over the past 33 years, AstraZeneca plc has delivered an average annual return of 14.3%. The stock peaked in 1995 with a massive +47.8% gain, while investors faced a downturn in 2004 (-24.4%). Overall, the stock finished in the green 25 times out of 33 years.
Avg Return
+14.3%
Win Rate
76%
25W - 8L
Best
+47.8%
1995
Worst
-24.4%
2004
Performance Consistency
AstraZeneca plc Annual Returns by Year
| Year | Annual Return | Start Price | End Price |
|---|---|---|---|
| 1993 | +25.35% | $1.69 | $2.12 |
| 1994 | +16.10% | $2.11 | $2.45 |
| 1995 | +47.76% | $2.44 | $3.61 |
| 1996 | +44.88% | $3.66 | $5.30 |
| 1997 | +34.75% | $5.18 | $6.99 |
| 1998 | +25.85% | $7.05 | $8.87 |
| 1999 | -7.34% | $9.03 | $8.37 |
| 2000 | +30.64% | $8.25 | $10.77 |
| 2001 | -6.77% | $10.64 | $9.92 |
| 2002 | -21.94% | $9.76 | $7.62 |
| 2003 | +41.68% | $7.57 | $10.72 |
| 2004 | -24.41% | $10.86 | $8.21 |
| 2005 | +37.55% | $8.17 | $11.24 |
| 2006 | +9.48% | $11.63 | $12.74 |
| 2007 | -18.00% | $12.82 | $10.51 |
| 2008 | +1.10% | $10.41 | $10.53 |
| 2009 | +21.65% | $10.42 | $12.67 |
| 2010 | +2.49% | $12.80 | $13.12 |
| 2011 | +5.66% | $13.16 | $13.91 |
| 2012 | +5.26% | $14.34 | $15.09 |
| 2013 | +30.49% | $15.40 | $20.10 |
| 2014 | +25.24% | $19.83 | $24.83 |
| 2015 | +0.48% | $24.84 | $24.96 |
| 2016 | -14.43% | $24.56 | $21.01 |
| 2017 | +31.37% | $21.31 | $28.00 |
| 2018 | +11.67% | $28.55 | $31.88 |
| 2019 | +36.33% | $31.73 | $43.25 |
| 2020 | +2.04% | $43.71 | $44.60 |
| 2021 | +18.47% | $45.08 | $53.40 |
| 2022 | +19.03% | $53.46 | $63.63 |
| 2023 | -0.80% | $65.07 | $64.55 |
| 2024 | -2.14% | $65.55 | $64.15 |
| 2025 | +42.52% | $64.50 | $91.93 |
Historical annual returns for AstraZeneca plc. Data shows year-over-year percentage change in stock price.
Why Use a "What If" Stock Calculator?
Many investors wonder questions such as:
- What if I had invested 5 years ago?
- How does timing affect long-term returns?
- What role does compounding play in stock investments?
A what-if investment calculator answers these questions by turning historical data into practical insights. Rather than focusing on daily price movements, it encourages a long-term perspective, which is especially useful for retirement planning, portfolio comparisons, and financial education.
Key Innovations
- ✓Development of Xylocaine (lidocaine), a widely used local anesthetic.
- ✓Significant contributions to cardiovascular and respiratory medicines.
- ✓Development of a COVID-19 vaccine in collaboration with the University of Oxford.
Business Segments
- OncologyFocuses on developing medicines for various types of cancer.
- Rare DiseaseDevelops treatments for a range of rare diseases.
- BioPharmaceuticalsIncludes medicines for cardiovascular, renal & metabolism, and respiratory & immunology diseases.
How to Interpret the Results
The results shown are based on historical performance and are meant for educational and informational purposes only. They do not account for future market conditions, taxes, transaction fees, or individual investment strategies. Past performance does not guarantee future results, but historical analysis can help investors understand risk, volatility, and growth potential.
For best use:
- Compare multiple time ranges to see how outcomes differ
- Use consistent assumptions across different stocks
- Combine this tool with fundamental research and diversification principles